What happened
Models trained on 39,312 measured compounds predicted activity and cytotoxicity; explainable substructure rationales guided purchase and testing of 283 molecules. Two related compounds reduced MRSA burden about tenfold in skin and thigh infection models and showed low human-cell toxicity. Candidates remain preclinical. Update (2023-12-04): ARC Evals is now METR December 4, 2023 ARC Evals is wrapping up our incubation period at ARC, and spinning off into our own standalone nonprofit. Read more. ARC Evals is now METR December 4, 2023 ARC Evals is wrapping up our incubation period at ARC, and spinning off into our own standalone nonprofit. Read more
